Trials / Completed
CompletedNCT06875362
Probiotic LR08 Improves Gut and Metabolism
Safety and Efficacy of LR08 in Modulating Gut Microbiota and Improving Metabolic Health in Healthy Adults: A Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the efficacy and safety of LR08 as a dietary supplement compared to a placebo in enhancing intestinal health and immune function in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2). |
| DIETARY_SUPPLEMENT | Placebo | The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2). |
Timeline
- Start date
- 2025-03-10
- Primary completion
- 2025-05-30
- Completion
- 2025-06-30
- First posted
- 2025-03-13
- Last updated
- 2025-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06875362. Inclusion in this directory is not an endorsement.